Search results for "antibody therapy"

Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its CDK7-inhibiting oncology candidate,...
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural restoration of the intestinal...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery

MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery

MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...
Osteoporosis Drugs That Can Be Hard to Keep Taking…Could ‘Sleeping Bone Cells’ Offer a Breakthrough?

Osteoporosis Drugs That Can Be Hard to Keep Taking…Could ‘Sleeping Bone Cells’ Offer a Breakthrough?

Some patients need to rebuild bone quickly. These are people at high fracture risk—those who have already broken a bone...
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects

Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects

A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound...
Vabysmo Prefilled Syringe Gains Reimbursement, Expanding Retina Treatment Options

Vabysmo Prefilled Syringe Gains Reimbursement, Expanding Retina Treatment Options

Injectable therapies for chronic eye diseases are entering a new era where clinicians and patients can select...